Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark · Delayed Price · Currency is DKK 3.070
+0.010 (0.33%)
Jul 28, 2026, 4:48 PM CET
CPH:SMSMED Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 214.99 | 245.44 | 226.68 | 191.19 | 110.53 | 71.64 | |
Revenue Growth | -12.41% | 8.28% | 18.56% | 72.98% | 54.29% | - |
Cost of Revenue | 187.67 | 211.16 | 186.58 | 156.46 | 87.85 | 57.76 |
Gross Profit | 27.32 | 34.28 | 40.1 | 34.73 | 22.68 | 13.88 |
Selling, General & Admin | 24.35 | 23.76 | 19.09 | 13.65 | 7.33 | 2.98 |
Depreciation & Amortization Expenses | 9.79 | 8.62 | 7.26 | 4.46 | 0.61 | 0.02 |
Other Operating Expenses | - | 0.1 | 0 | - | - | - |
Total Operating Expenses | 34.14 | 32.49 | 26.35 | 18.1 | 7.94 | 3.01 |
Operating Income | -6.82 | 1.79 | 13.75 | 16.63 | 14.74 | 10.87 |
Interest Income | - | 0 | 0 | 0 | 0.22 | 0.2 |
Interest Expense | -2.37 | -2.15 | -5.23 | -0.98 | -0.25 | -0.54 |
Total Non-Operating Income (Expense) | -2.37 | -2.15 | -5.23 | -0.98 | -0.03 | -0.33 |
Pretax Income | -9.94 | 0.22 | 10.07 | 15.79 | 14.71 | 10.54 |
Provision for Income Taxes | -2.3 | 0.19 | 2.28 | 3.57 | 3.34 | 2.38 |
Net Income | -7.64 | 0.03 | 7.79 | 12.22 | 11.37 | 8.16 |
Net Income to Common | -7.64 | 0.03 | 7.79 | 12.22 | 11.37 | 8.16 |
Net Income Growth | - | -99.67% | -36.30% | 7.49% | 39.42% | 80.82% |
Shares Outstanding (Basic) | 28 | 28 | 27 | 27 | 27 | 3 |
Shares Outstanding (Diluted) | 28 | 28 | 27 | 27 | 27 | 3 |
Shares Change | 0.27% | 0.67% | 0.57% | 2.22% | 707.62% | 3207.00% |
EPS (Basic) | -0.28 | - | 0.28 | 0.45 | 0.43 | 2.47 |
EPS (Diluted) | -0.28 | - | 0.28 | 0.45 | 0.43 | 2.47 |
EPS Growth | - | - | -37.78% | 4.65% | -82.59% | -94.52% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -23.62 | -34.22 | -15.08 | -49.19 | -24.33 | 4.02 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.85 | -1.24 | -0.55 | -1.80 | -0.91 | 1.22 |
Gross Margin | 12.71% | 13.97% | 17.69% | 18.16% | 20.52% | 19.38% |
Operating Margin | -3.17% | 0.73% | 6.07% | 8.70% | 13.34% | 15.18% |
Profit Margin | -3.55% | 0.01% | 3.44% | 6.39% | 10.29% | 11.39% |
FCF Margin | -10.99% | -13.94% | -6.65% | -25.73% | -22.01% | 5.62% |
EBITDA | 2.97 | 10.51 | 21.01 | 21.08 | 15.35 | 10.9 |
EBITDA Margin | 1.38% | 4.28% | 9.27% | 11.03% | 13.89% | 15.21% |
EBIT | -6.82 | 1.79 | 13.75 | 16.63 | 14.74 | 10.87 |
EBIT Margin | -3.17% | 0.73% | 6.07% | 8.70% | 13.34% | 15.18% |
Effective Tax Rate | 23.11% | 87.91% | 22.66% | 22.60% | 22.70% | 22.61% |